Featured Research

from universities, journals, and other organizations

New cell therapy to prevent organ rejection

Date:
May 18, 2011
Source:
King's College London
Summary:
Researchers have used cells found naturally in the body, to re-educate the immune system to prevent rejection of an organ transplant while remaining capable of fighting infections and cancer.

New cell therapy to prevent organ rejection could remove the need for life-long medication and boost the longevity of a transplant for patients

Researchers at King's College London have used cells found naturally in the body, to re-educate the immune system to prevent rejection of an organ transplant while remaining capable of fighting infections and cancer.

Currently, patients must take immunosuppressant drugs to prevent a new organ from being rejected after transplantation. However, these drugs suppress the entire immune system, leaving the patient susceptible to infections and tumours.

Scientists say this new approach using immune cells, called regulatory T cells (Tregs), from the body could eliminate the need for immunosuppression, as the Tregs used will only suppress the activity of those cells which will attack the new organ, rather than suppress the whole immune system. The team says these results are encouraging. Ultimately this approach could extend the life of a transplanted organ and in turn, could alleviate the organ shortage problem.

The study, to be published in Science Translational Medicine, was carried out at King's by scientists in its Medical Research Council Centre for Transplantation. King's College London is part of King's Health Partners Academic Health Sciences Centre, a pioneering collaboration with NHS Trusts which aims to ensure that the latest research in health is used to improve patient care at the earliest opportunity.

The study was part-funded by the British Heart Foundation and the Wellcome Trust.

Tregs are known to control the activity of many different immune cells, including T effector cells, which are responsible for mounting immune responses against foreign organisms, such as bacteria during an infection, and an organ following transplantation. The team have developed a method to select Tregs that can regulate only the activity of effector cells that would target a transplanted organ ("specific" Tregs), leaving the remaining effector cells to function normally.

Using a humanised mouse, where a mouse lacking its own immune system was given human effector cells and Tregs, the team were able to test the ability of these "specific" Tregs to prevent rejection of human skin grafted onto the mouse. The team found that the "specific" Tregs were significantly more potent than non-specific Tregs (those able to inhibit all effector cells) in protecting skin grafts from immune damage.

Professor Robert Lechler, Vice-Principal for Health at King's and Executive Director of King's Health Partners, said: "This study is a promising step forward that could lead to dramatic advances in preventing organ rejection and improving the quality of life of transplant patients.

"Researchers at King's are in a unique position. On average it takes 17 years for research discoveries and medical breakthroughs to become routine clinical practice. But being an Academic Health Sciences Centre means that researchers work directly alongside clinicians at leading NHS Foundation Trusts to speed up the time it takes for research to get from bench to bedside. Because of this, we hope to begin first-in-man trials within five years and could see patients being given this novel cellular therapy in around ten years time."

If this approach were to be adopted to treat patients, blood would be sampled from a patient who will be receiving a transplant and their Tregs extracted from it. These Tregs would then be mixed with cells from the selected organ donor and the "specific" Tregs isolated using the new method developed by the team. The specific Tregs would then be expanded in numbers in a specialised sterile laboratory and be reintroduced into the patient after the transplant. Scientists believe this therapeutic approach will be applicable to the majority of solid organ transplants such as the kidney, heart and liver.

The King's study is one of three papers in Science Translational Medicine reporting progress towards immune cell therapies to prevent transplant rejection. Together, they make it possible to see how such therapies might work, if successfully developed.


Story Source:

The above story is based on materials provided by King's College London. Note: Materials may be edited for content and length.


Journal Reference:

  1. P. Sagoo, N. Ali, G. Garg, F. O. Nestle, R. I. Lechler, G. Lombardi. Human Regulatory T Cells with Alloantigen Specificity Are More Potent Inhibitors of Alloimmune Skin Graft Damage than Polyclonal Regulatory T Cells. Science Translational Medicine, 2011; 3 (83): 83ra42 DOI: 10.1126/scitranslmed.3002076

Cite This Page:

King's College London. "New cell therapy to prevent organ rejection." ScienceDaily. ScienceDaily, 18 May 2011. <www.sciencedaily.com/releases/2011/05/110518141706.htm>.
King's College London. (2011, May 18). New cell therapy to prevent organ rejection. ScienceDaily. Retrieved July 28, 2014 from www.sciencedaily.com/releases/2011/05/110518141706.htm
King's College London. "New cell therapy to prevent organ rejection." ScienceDaily. www.sciencedaily.com/releases/2011/05/110518141706.htm (accessed July 28, 2014).

Share This




More Health & Medicine News

Monday, July 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com
West Africa Gripped by Deadly Ebola Outbreak

West Africa Gripped by Deadly Ebola Outbreak

AFP (July 28, 2014) The worst-ever outbreak of the deadly Ebola epidemic grips west Africa, killing hundreds. Duration: 00:48 Video provided by AFP
Powered by NewsLook.com
Trees Could Save More Than 850 Lives Each Year

Trees Could Save More Than 850 Lives Each Year

Newsy (July 27, 2014) A national study conducted by the USDA Forest Service found that trees collectively save more than 850 lives on an annual basis. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins